9:22 AM
Leo Group India
| ||
| India to give free medicine to hundreds of millions Reuters India Under the plan, doctors will be limited to a generics-only drug list and face punishment for prescribing branded medicines, a major disadvantage for pharmaceutical giants in one of the world's fastest-growing drug markets. "Without a doubt, it is a ... See all stories on this topic » | ||
| Lupin receives FDA approval for Generic LYRICA Business Standard Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received final approval for its Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg from the United ... See all stories on this topic » | ||
| How India's 'free medicine to all' policy transforms lives NDTV Reuters, 05 Jul 2012 | 07:06 AM. Under the plan, doctors will be limited to a generics-only drug list and face punishment for prescribing branded medicines, a major disadvantage for pharmaceutical giants in one of the world's fastest-growing drug markets. See all stories on this topic » | ||
| Italy's pharmaceutical lobby attacks cuts Financial Times Italy's powerful pharmaceuticals lobby has added its voice to a growing chorus of protests from interest groups against planned spending cuts by Mario Monti's technocrat government. Ministers are expected to meet on Thursday evening to finalise the. See all stories on this topic » | ||
| Raptor Pharmaceutical Corp. to Present at the Seventh Annual JMP Securities ... MarketWatch (press release) NOVATO, Calif., Jul 5, 2012 (GlobeNewswire via COMTEX) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTP) , today announced that Patrice P. Rioux, M.D., Ph.D., Chief Medical Officer of Raptor, will present an overview of the ... See all stories on this topic » | ||
| Rs 27000 crore project for free medicines to start this year Economic Times In an ambitious project, government proposes to provide free medicines to millions of people through a Rs 27000 crore joint initiative of the Centre and states within this year. See all stories on this topic » | ||
| Pharmaceutical giant GlaxoSmithKline fined $3 billion World Socialist Web Site Monday's settlement is the latest in a long list of cases in which pharmaceutical giants have paid cash fines for fraudulent and criminal practices, without anyone being held accountable. See all stories on this topic » | ||
| Indian pharma: Pricey patented drugs do not seem the norm Economic Times There seems considerable policy action in the Indian pharmaceutical scene. There is the reported move to boost supply of essential drugs in government hospitals, the attempt to vet cross-border investments here and the first compulsory licence has been ... See all stories on this topic » | ||
| US threatens to take India to WTO over Nexavar Generic Economic Times The US has threatened to drag India to the WTO for issuing the firstever compulsory licence to a domestic company to manufacture generic version of Bayer's cancer drug Nexavar. See all stories on this topic » | ||
| NAFDAC celebrates herbal pharmaceutical practice in Nigeria The Guardian Nigeria The agency has also lauded herbal pharmaceutical practice and the upsurge in use of herbal medicines in the country. Director General of NAFDAC, Dr. Paul Orhii, who was represented by Mrs. E. M. Amuta, made this known at Kedi Healthcare Car Awards ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment